2-Methyl-2-Propanyl(1R,8S)-4-Nitro-11-Azatricyclo[6.2.1.02,7]Undeca-2,4,6-Triene-11-Carboxylate
98%
- Product Code: 212852
CAS:
942492-09-3
Molecular Weight: | 290.31 g./mol | Molecular Formula: | C₁₅H₁₈N₂O₄ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C |
Product Description:
Used as a key intermediate in the synthesis of complex nitrogen-containing pharmaceuticals, particularly in the development of neuroactive agents and central nervous system modulators. Its rigid tricyclic structure and defined stereochemistry make it valuable for constructing selective ligands targeting neurotransmitter receptors. The nitro group allows further functionalization, enabling the introduction of amine or other pharmacophoric elements. The tert-butoxycarbonyl (Boc) protecting group ensures compatibility in multi-step peptide-like syntheses, providing controlled deprotection under mild acidic conditions. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its ability to lock conformations and enhance metabolic stability in drug candidates.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
250mg | 10-20 days | £5,724.25 |
+
-
|
2-Methyl-2-Propanyl(1R,8S)-4-Nitro-11-Azatricyclo[6.2.1.02,7]Undeca-2,4,6-Triene-11-Carboxylate
Used as a key intermediate in the synthesis of complex nitrogen-containing pharmaceuticals, particularly in the development of neuroactive agents and central nervous system modulators. Its rigid tricyclic structure and defined stereochemistry make it valuable for constructing selective ligands targeting neurotransmitter receptors. The nitro group allows further functionalization, enabling the introduction of amine or other pharmacophoric elements. The tert-butoxycarbonyl (Boc) protecting group ensures compatibility in multi-step peptide-like syntheses, providing controlled deprotection under mild acidic conditions. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its ability to lock conformations and enhance metabolic stability in drug candidates.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
£0.00
£0.00
Total :